Type-Specific Cervico-Vaginal Human Papillomavirus Infection Increases Risk of HIV Acquisition Independent of Other Sexually Transmitted Infections

被引:76
|
作者
Smith-McCune, Karen K. [1 ,2 ]
Shiboski, Stephen [3 ]
Chirenje, Mike Z. [6 ]
Magure, Tsitsi [6 ]
Tuveson, Jennifer [1 ]
Ma, Yifei [4 ]
Da Costa, Maria [5 ]
Moscicki, Anna-Barbara [2 ,4 ]
Palefsky, Joel M. [2 ,5 ]
Makunike-Mutasa, Rudo [6 ]
Chipato, Tsungai [6 ]
van der Straten, Ariane [5 ,7 ]
Sawaya, George F. [1 ,2 ,3 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[6] Univ Zimbabwe, Dept Obstet & Gynecol, Harare, Zimbabwe
[7] RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA
来源
PLOS ONE | 2010年 / 5卷 / 04期
关键词
LUBRICANT GEL; WOMEN; CLASSIFICATION; DIAPHRAGM; VACCINE; SYSTEM; HERPES; CELLS;
D O I
10.1371/journal.pone.0010094
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Sexually transmitted infections (STIs) such as herpes simplex virus (HSV)-2 are associated with an increased risk of HIV infection. Human papillomavirus (HPV) is a common STI, but little is know about its role in HIV transmission. The objective of this study was to determine whether cervico-vaginal HPV infection increases the risk of HIV acquisition in women independent of other common STIs. Methods and Findings: This prospective cohort study followed 2040 HIV-negative Zimbabwean women (average age 27 years, range 18-49 years) for a median of 21 months. Participants were tested quarterly for 29 HPV types (with L1 PCR primers) and HIV (antibody testing on blood samples with DNA or RNA PCR confirmation). HIV incidence was 2.7 per 100 woman-years. Baseline HPV prevalence was 24.5%, and the most prevalent HPV types were 58 (5.0%), 16 (4.7%), 70 (2.4%), and 18 (2.3%). In separate regression models adjusting for baseline variables (including age, high risk partner, positive test for STIs, positive HSV-2 serology and condom use), HIV acquisition was associated with having baseline prevalent infection with HPV 58 (aHR 2.13; 95% CI 1.09-4.15) or HPV 70 (aHR 2.68; 95% CI 1.08-6.66). In separate regression models adjusting for both baseline variables and time-dependent variables (including HSV-2 status, incident STIs, new sexual partner and condom use), HIV acquisition was associated with concurrent infection with any non-oncogenic HPV type (aHR 1.70; 95% CI 1.02-2.85), any oncogenic HPV type (aHR 1.96; 95% CI 1.16-3.30), HPV 31 (aHR 4.25; 95% CI 1.81-9.97) or HPV 70 (aHR 3.30; 95% CI 1.50-7.20). Detection of any oncogenic HPV type within the previous 6 months was an independent predictor of HIV acquisition, regardless of whether HPV status at the HIV acquisition visit was included (aHR 1.95; 95% CI 1.19-3.21) or excluded (aHR 1.96; 95% CI 1.02-2.85) from the analysis. Conclusions/Significance: Cervico-vaginal HPV infection was associated with an increased risk of HIV acquisition in women, and specific HPV types were implicated in this association. The observational nature of our study precludes establishment of causation between HPV infection and HIV acquisition. However, given the high prevalence of HPV infection in women, further investigation of the role of HPV in HIV transmission is warranted.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology
    Ali, Mohamed A. M.
    Bedair, Rania N.
    Abd El Atti, Rasha M.
    CANCER CYTOPATHOLOGY, 2019, 127 (09) : 567 - 577
  • [42] Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women
    Watts, DH
    Fazarri, M
    Minkoff, H
    Hillier, SL
    Sha, B
    Glesby, M
    Levine, AM
    Burk, R
    Palefsky, JM
    Moxley, M
    Ahdieh-Grant, L
    Strickler, HD
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (07): : 1129 - 1139
  • [43] Preventing human immunodeficiency virus (HIV) and other sexually transmitted infections and reducing HIV-stigmatizing attitudes in high-risk youth: Evaluation of a comprehensive community-based and peer-facilitated curriculum
    Zuniga, Mana Luisa
    Blanco, Estela
    Sanchez, Lizette M.
    Carroll, Stephen P.
    Olshefsky, Alisa M.
    VULNERABLE CHILDREN AND YOUTH STUDIES, 2009, 4 (04) : 333 - 345
  • [44] A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study
    Schiffman, Mark
    Glass, Andrew G.
    Wentzensen, Nicolas
    Rush, Brenda B.
    Castle, Philip E.
    Scott, David R.
    Buckland, Julie
    Sherman, Mark E.
    Rydzak, Greg
    Kirk, Peter
    Lorincz, Attila T.
    Wacholder, Sholom
    Burk, Robert D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) : 1398 - 1409
  • [45] RISK-FACTORS FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION IN PATIENTS AT A SEXUALLY-TRANSMITTED DISEASE CLINIC IN NEW-YORK-CITY
    CHIASSON, MA
    STONEBURNER, RL
    LIFSON, AR
    HILDEBRANDT, DS
    EWING, WE
    SCHULTZ, S
    JAFFE, HW
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (02) : 208 - 220
  • [46] Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. (vol 66, pg 535, 2002)
    Forslund, O
    Antonsson, A
    Edlund, K
    van den Brule, AJC
    Hansson, BG
    Meijer, CJLM
    Ryd, W
    Rylander, E
    Strand, A
    Wadell, G
    Dillner, J
    Johansson, B
    JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (03) : 467 - 467
  • [47] HIGH SOCIOECONOMIC-STATUS IS A RISK FACTOR FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION BUT NOT FOR SEXUALLY-TRANSMITTED DISEASES IN WOMEN IN MALAWI - IMPLICATIONS FOR HIV-1 CONTROL
    DALLABETTA, GA
    MIOTTI, PG
    CHIPHANGWI, JD
    SAAH, AJ
    LIOMBA, G
    ODAKA, N
    SUNGANI, F
    HOOVER, DR
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01): : 36 - 42
  • [48] Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naive women: results from the control arm of a phase II HPV-16/18 vaccine trial
    Ramanakumar, Agnihotram V.
    Naud, Paulo
    Roteli-Martins, Cecilia M.
    de Carvalho, Newton S.
    de Borba, Paola C.
    Teixeira, Julio C.
    Blatter, Mark
    Moscicki, Anna-Barbara
    Harper, Diane M.
    Romanowski, Barbara
    Tyring, Stephen K.
    Ramjattan, Brian
    Schuind, Anne
    Dubin, Gary
    Franco, Eduardo L.
    BMJ OPEN, 2016, 6 (08):
  • [49] A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia among 20,000 Women in the Portland Kaiser Cohort Study (vol 20, pg 1398, 2011)
    Schiffman, M.
    Glass, A. G.
    Wentzensen, N.
    Rush, B. B.
    Castle, P. E.
    Scott, D. R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (08) : 1390 - 1391
  • [50] Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection among HIV-1-infected and high-risk HIV-1-uninfected women. (vol 191, pg 1129, 2005)
    Watts, DH
    Fazarri, SM
    Minkoff, H
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (05): : 943 - 943